Renal outcomes in the ONTARGET study.
Nonoguchi
Hiroshi
H
Nanami
Masayoshi
M
Hasuike
Yukiko
Y
Kuragano
Takahiro
T
Nakanishi
Takeshi
T
D047228:Angiotensin II Type 1 Receptor Blockers / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D006801:Humans; D018579:Patient Selection; D011507:Proteinuria / Q000139:chemically induced*
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors